Researchers at the University of Colorado Anschutz Medical Campus have uncovered a critical, previously underappreciated role ...

B cells are now reported, in a recent paper in Nature, to have their own immunological synapses with APCs. Only this time the antigen is whole and B cells don't keep it to themselves.

The young biotech, sprung out of a Versant incubator in Switzerland, has a pair of antibody drugs it claims to have the ...

Sanofi is continuing to splash the cash for autoimmune and immunology assets this spring by penning a new deal with ...

At the heart of the licensing deal is CUE-501, a bispecific molecule that can selectively deplete B cells to address ...

Granite will focus on two antibody therapies, both targeting crucial players in the inflammatory cascade to address ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...

People commonly refer to these as B cells and T cells. The job of T cells is to help the body kill cancer cells and control the immune response to foreign substances. They do this by destroying ...

Dren Bio deep B-cell depleter program has the potential to reset the immune system Acquisition underpins path for Sanofi becoming leading immunology company Sanofi to pay $600 million up front ...